Obesity is a risk factor for type 2 diabetes mellitus (T2DM), and some evidence from animal studies suggests that treatment with GDF-15 decreases body weight and glucose levels, primarily due to the loss of fat mass and reduced food intake [17]. The gene discussed is GDF15; the disease is obesity disorder.